Kodiak Sciences Inc Common Stock
KOD Real Time Price USDRecent trades of KOD by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by KOD's directors and management
Government lobbying spending instances
Estimated quarterly lobbying spending
New patents grants
-
Patent Title: Il-6 antibodies and fusion constructs and conjugates thereof Aug. 27, 2024
-
Patent Title: Methods of treating an eye disorder Feb. 27, 2024
-
Patent Title: Multifunctional zwitterionic polymer conjugates Nov. 21, 2023
-
Patent Title: Factor viii zwitterionic polymer conjugates Feb. 28, 2023
-
Patent Title: Complement factor d antagonist antibodies and conjugates thereof Feb. 21, 2023
-
Patent Title: Dual pdgf/vegf antagonists Oct. 26, 2021
-
Patent Title: Butyrylcholinesterase zwitterionic polymer conjugates Jul. 27, 2021
-
Patent Title: Antibodies and conjugates thereof Jul. 20, 2021
-
Patent Title: Factor viii zwitterionic polymer conjugates Jul. 07, 2020
-
Patent Title: Butyrylcholinesterase zwitterionic polymer conjugates Jul. 30, 2019
-
Patent Title: Dual pdgf/vegf antagonists Dec. 12, 2017
Federal grants, loans, and purchases
Estimated quarterly amount awarded from public contracts
Number of mentions of KOD in WallStreetBets Daily Discussion
Recent insights relating to KOD
Recent picks made for KOD stock on CNBC
ETFs with the largest estimated holdings in KOD
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view KOD Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.